Q2 2025 Holdings
Filed 2025-08-14 | 36 holdings | $84.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $6.9M | 962,951 | 8.2% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $6.5M | 68,982 | 7.7% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $5.1M | 40,608 | 6.0% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $4.8M | 1,286,681 | 5.7% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $4.7M | 130,422 | 5.6% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $4.7M | 134,895 | 5.6% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $4.7M | 44,107 | 5.5% |
| Soleno Therapeutics Inc(SLNO)Put | COM | 834203309 | $4.2M | 50,000 | 5.0% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $4.2M | 96,766 | 4.9% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $4.1M | 276,474 | 4.8% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $3.9M | 98,267 | 4.6% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $3.5M | 344,922 | 4.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $2.8M | 33,691 | 3.3% |
| Savara Inc(SVRA) | COM | 805111101 | $2.5M | 1,115,379 | 3.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $2.1M | 212,377 | 2.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $2.0M | 61,103 | 2.4% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $1.8M | 189,699 | 2.1% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.6M | 1,060,764 | 1.9% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $1.6M | 79,058 | 1.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.5M | 14,571 | 1.7% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $1.4M | 4,874 | 1.7% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $1.3M | 47,037 | 1.6% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $1.2M | 87,912 | 1.4% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $1.1M | 360,000 | 1.3% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $1.1M | 111,605 | 1.3% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $885.5K | 71,071 | 1.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $831.8K | 17,623 | 1.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $825.7K | 88,980 | 1.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $525.3K | 214,412 | 0.6% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $456.6K | 70,242 | 0.5% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $450.0K | 250,000 | 0.5% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $437.6K | 142,542 | 0.5% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $258.7K | 462,963 | 0.3% |
| SO Young International Inc(SY) | SPONSORED ADS | 83356Q108 | $226.1K | 72,936 | 0.3% |
| Rapt Therapeutics Inc(RAPT) | COM NEW | 75382E208 | $208.3K | 26,034 | 0.2% |
| Lakeshore Biopharma Co LTD | ORD SHS NEW | G9845F208 | $31.4K | 30,792 | 0.0% |